COMMUNIQUÉS West-GlobeNewswire

-
CytomX Therapeutics Added to NASDAQ Biotechnology Index
18/12/2017 -
Aduro Biotech Announces the Initiation of a Phase 1/2 Clinical Trial of BION-1301, a Novel Anti-APRIL Antibody, for the Treatment of Multiple Myeloma
18/12/2017 -
Opiant Pharmaceuticals Announces Publication of New Pre-Clinical Data Supporting Potential of OPNT005 as a Heroin Vaccine
18/12/2017 -
Athenex, Inc. Added to Nasdaq Biotechnology Index
18/12/2017 -
Biotricity Achieves FDA 510(k) Clearance for its Bioflux Device
18/12/2017 -
Pain Therapeutics Reports Positive Regulatory Meeting for REMOXY™
18/12/2017 -
Interpace Diagnostics Announces Agreement with ARUP Laboratories
18/12/2017 -
Catalyst Biosciences Announces Acceleration of Phase 1/2 Trial of CB 2679d/ISU304 in Individuals with Hemophilia B
18/12/2017 -
Arch Therapeutics Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA
18/12/2017 -
EDAP's Focal One® Robotic HIFU Treatments Performed at Acibadem Hospital, Istanbul, Turkey
18/12/2017 -
ICU Medical, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference
18/12/2017 -
REPEAT – Cannabis Wheaton Income Corp. Announces Sustainable Growth Strategic Capital Corp. as New Wheaton Streaming Partner
18/12/2017 -
Kura Oncology Added to Nasdaq Biotechnology Index
18/12/2017 -
Innovation Pharmaceuticals Brilacidin Oral Mucositis Program Moving Forward Based Upon Positive Anchoring Phase 2 Results and Increased Brilacidin Franchise Value
18/12/2017 -
Intellia Therapeutics Names John Leonard, M.D., President and Chief Executive Officer
18/12/2017 -
Major shareholder announcement
18/12/2017 -
Sanofi and Alnylam submit Marketing Authorization Application to the European Medicines Agency for patisiran for the treatment of hereditary ATTR amyloidosis
18/12/2017 -
Sanofi et Alnylam présentent une demande d'autorisation de mise sur le marché à l'Agence européenne des médicaments pour le patisiran dans le traitement de l'amylose héréditaire à transthyrétine
18/12/2017 -
Deciphera Pharmaceuticals, Inc. Added to Russell 2000® Index
18/12/2017
Pages